Blackmores inks deal with psychobiotic supplier Bened

By Tingmin Koe

- Last updated on GMT

The probiotic strain PS128 has shown to improve social communication, and reduces defiance and hyperactivity in children. ©Getty Images
The probiotic strain PS128 has shown to improve social communication, and reduces defiance and hyperactivity in children. ©Getty Images

Related tags Blackmores Australia Probiotics Brain

Bened has sealed a deal with the Blackmores Group to supply its proprietary probiotic strain PS128.

The exclusive partnership with Blackmores marks Bened’s debut in the ANZ markets, and the two will co-develop the end product formulation containing the PS128 strain.

PS128 is a Lactobacillus plantarum​ strain which modulates the microbiota-gut-brain axis by increasing the serotonin and dopamine concentration in key brain areas, such as the hippocampus and frontal cortex.

This in turn improves mental wellbeing by reducing symptoms such as stress, anxiety, and insomnia.

It won the Probiotic Product of the Year award​ during the NutraIngredients-Asia Awards two years ago.

The strain will be incorporated into probiotic products under the Blackmores brands, including the practitioner-only brand BioCeuticals – which will be the first in the group to launch PS128 products, Alain Delpy, the head of international business development at Bened told NutraIngredients-Asia.

The cooperation was conceived during a meeting organised by the office of Austrade in Taipei.

Delpy added that the probiotic strains made in Europe, would be sent to Australia for the manufacturing of the final product in a third-party factory.

“We are very happy to cooperate with Blackmores because it is a very big health and nutrition company in APAC.

“PS128 is already very successful in Europe, we are present in more than 10 countries, such as France, Germany, Spain, Italy,”​ he said, revealing that the continent is the firm’s largest market.


Some of Bened’s commercial partners in the region include UK firm OptiBiotix​ and the Neuraxpharm Group from Germany.

Elsewhere in Asia, Delpy said the company was predominantly present in Taiwan, followed by South East Asia countries Malaysia and Singapore.

He revealed that the company was planning to enter the Philippines and was already at the phase of product registration. The process is expected to complete by April.

Clinical trials

The company has recently completed a clinical trial using PS128 on Asian Parkinson patients, with results due for publication in a few months’ time.

Another trial on PS128’s stress reliving effects is still in progress, Delpy said, adding that the company largely conducts its trials in Asia.

One of its previous trials​ involving 80 autistic children aged seven to 15 showed that the daily intake of PS128 had improved social communication, interaction deficits, as well as anxiety, defiance, and hyperactivity.

The company has developed a second proprietary probiotic strain – PS23​ which also has anti-anxiety effects.

Related news

Show more

Related products

show more

Krill oil supports six key areas of healthy aging

Krill oil supports six key areas of healthy aging

Content provided by Aker BioMarine | 26-Feb-2024 | White Paper

The global population is getting older—according to WHO by 2050 the world’s population over 60 years will double and the population above 80 years will...

Nootropics Report 2.0: Brain Health Insights

Nootropics Report 2.0: Brain Health Insights

Content provided by dsm-firmenich | 22-Feb-2024 | Insight Guide

The brain health market is constantly growing and evolving, with more consumers looking for innovative ways to support total mind and body wellness.

Revolutionizing Brain Health with BioKesum®

Revolutionizing Brain Health with BioKesum®

Content provided by Biotropics Malaysia | 20-Feb-2024 | Data Sheet

Revitalize the nootropic industry with new clinically proven herbal extract from Kesum leaves shown to improve executive memory, mood and brain markers...

Pycnogenol® Supports Cognitive Function at Any Age

Pycnogenol® Supports Cognitive Function at Any Age

Content provided by Horphag Research | 07-Feb-2024 | White Paper

Clinical research shows daily supplementation with Pycnogenol® French maritime pine bark extract may help support brain function in a variety of age groups...

Follow us


View more


Nutra Champions Podcast

Nutra Champions Podcast